CRTX Financial Facts
Net income (loss) per share, basic: 0.36Total other expenses: -1.79M
See Full Income Statement
Additional paid-in capital: 170.24M
Retained earnings: 16.44M
See Full Balance Sheet
Cornerstone Therapeutics Inc. (CRTX) Earnings
|
Expand Research on CRTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -68.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/22/22 | Q222 | N/A | -$0.55 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/7/13  |
 |
Q313 | $0.46 | $0.27 | +$0.19 | $53.7M | $42M | N/A |  | | Details |
| 8/6/13 | Q213 | $0.19 | $0.12 | +$0.07 | $40.4M | $35.79M | N/A | | | Details | |
| 3/14/13 | Q412 | -$0.26 | $0.10 | -$0.36 | $34.93M | $36.04M | N/A | | | Details | |
| 11/8/12 | Q312 | $0.19 | $0.32 | -$0.13 | $37.5M | $32M | N/A | | | Details | |
| 8/9/12 | Q212 | -$0.17 | -$0.02 | -$0.15 | $21.47M | $18.84M | N/A | | | Details | |
| 5/15/12 |
Q112 | $0.05 | $0.10 | -$0.05 | $22.2M | $20M | N/A | | | Details | |
| 3/8/12 | Q411 | -$0.06 | $0.09 | -$0.15 | $18.21M | $24.58M | N/A | | | Details |
